Skip to main content

Month: September 2020

TELUS’ Darren Entwistle recognized as CEO Achiever, Champion of the Year by CEO World Awards®

VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) — Today, TELUS proudly announced that its CEO, Darren Entwistle, has been named the Gold Winner of the CEO Achiever – Champion of the Year Award in the Eighth Annual 2020 CEO World Awards®. The award recognizes Darren’s leadership in leveraging TELUS’ technology and social purpose to support Canadians, particularly our most vulnerable citizens, as they grapple with the COVID-19 pandemic.Darren’s leadership during the public health crisis reflects his 20-year legacy of supporting his team, and the communities in which TELUS lives, works, and serves. As a global leader in social capitalism, TELUS believes that good business and doing good are mutually inclusive. That’s why the TELUS team has contributed $1.3 billion in value, time, and financial support to Canadian...

Continue reading

Darren Entwistle reçoit le prix CEO Achiever – Champion of the Year récompensant le président et chef de la direction le plus performant de l’année aux CEO World Awards(MD)

VANCOUVER, Colombie-Britannique, 09 sept. 2020 (GLOBE NEWSWIRE) — Aujourd’hui, TELUS a fièrement annoncé que son président et chef de la direction, Darren Entwistle, a reçu le prix CEO Achiever – Champion of the Year récompensant le président et chef de la direction le plus performant de l’année dans la catégorie Or lors de la huitième édition annuelle (2020) des CEO World AwardsMD. Ce prix souligne le leadership dont il a fait preuve en tirant parti de la technologie et de la vocation sociale de TELUS pour aider les Canadiens, en particulier les citoyens les plus vulnérables, à faire face à la pandémie de COVID-19.Le leadership exercé par M. Entwistle durant la crise sanitaire est le reflet de ses 20 années passées à soutenir son équipe ainsi que les collectivités que les membres de l’équipe TELUS servent et dans lesquelles ils...

Continue reading

Fancamp Announces the Appointment of Interim Chief Executive Officer

VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX VENTURE: FNC) announces that, effective immediately, Mr. Rajesh Sharma, has been appointed as Interim Chief Executive Officer of the Corporation.Mr. Sharma has over 25 years of global experience in mining, metals and international trade. Most recently, he worked with Investissement Québec (“IQ”) as an executive in residence, advising IQ on foreign direct investment, exports and partnerships with India and attracting mining and infrastructure investments globally. From 2011 to 2019, Mr. Sharma worked with Tata Steel Mineral Canada (“TSMC”), a joint venture among Tata Steel, New Millennium Iron and Ressources Québec. He served as CEO of TSMC until June 2018 and then as a strategic advisor to the board until...

Continue reading

Medical Marijuana, Inc. Subsidiary Kannaway® Signs Trademark License and Royalty Agreement with Direct Selling Pet Food Company, Onboards Company’s Brand Ambassadors

SAN DIEGO, CA, Sept. 09, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has signed a Trademark License and Royalty Agreement with direct selling company The Best Friend (“TBF”). As a part of the agreement, the new venture, TBF by Kannaway®, will sell a super-premium line of veterinarian-developed pet food products, as well as a line of cannabidiol (CBD) tinctures designed for pets, throughout Europe.These pet food products are created by a research and development team composed of world-renowned premium dog breeders, scientists and veterinarians. They have been...

Continue reading

OrthoPediatrics Corp. to Sponsor Two Medical Meetings in September 2020

WARSAW, Ind., Sept. 09, 2020 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support for the Scoliosis Research Society (“SRS”), including the Company’s Gold Level sponsorship for the 55th Annual Meeting & Course taking place virtually on September 9-13. The Company will also continue its support as a Platinum Level Sponsor for the 74th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine (“AACPDM”), which will take place virtually on September 23-26.In addition to its sponsorship, OrthoPediatrics will provide educational grants and scholarships for physicians to attend SRS. SRS meeting attendees are invited to join discussions featuring ApiFix...

Continue reading

Dynacor Declares Its Q3-2020 Quarterly Dividend

MONTREAL, Sept. 09, 2020 (GLOBE NEWSWIRE) — Dynacor Gold Mines Inc. (TSX: DNG) (Dynacor or the Corporation) is pleased to announce the declaration of a dividend payment of CA $0.015 per common share which will be payable on October 5, 2020, to shareholders of record as of the close of business on September 18, 2020. This dividend represents the 9th quarterly dividend payment made to shareholders. The Corporation’s quarterly dividend qualifies as an “eligible dividend” for Canadian income tax purposes.The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board.ABOUT DYNACORDynacor is a dividend-paying gold production corporation headquartered in Montreal, Canada. The corporation is engaged...

Continue reading

Dynacor déclare son dividende trimestriel T3-2020

MONTRÉAL, 09 sept. 2020 (GLOBE NEWSWIRE) — Mines d’or Dynacor Inc. (TSX: DNG) (OTC: DNGDF) (Dynacor ou la Société) a le plaisir d’annoncer la déclaration de son  dividende trimestriel de 0,015$ CA, qui sera payé le 5 octobre 2020 aux actionnaires inscrits à la clôture en date du 18 septembre 2020. Ce dividende représente le neuvième (9è) dividende trimestriel payé par la société à ses actionnaires.Ce dividende se qualifie comme ‘‘dividendes déterminés’’ aux fins de l’impôt canadien sur le revenu.Le versement et l’augmentation de dividendes sont à la discrétion du Conseil d’administration et dépendent des résultats financiers de la Société, de ses besoins en liquidités, des perspectives futures et d’autres facteurs jugés pertinents par le Conseil.À PROPOS DE DYNACORDynacor est une société payant des dividendes et ayant son siège...

Continue reading

b1BANK Names Jesse Jackson to Lead Financial Institutions Group

BATON ROUGE, La., Sept. 09, 2020 (GLOBE NEWSWIRE) — Jude Melville, president and CEO of b1BANK, announced Jesse Jackson will lead the bank’s Financial Institutions Group and will join the executive leadership team. Jackson has over 30 years’ experience in the banking industry, most recently serving as executive vice president of Texas Capital Bank’s Dallas Commercial Banking Practice. Jackson was also instrumental in building their correspondent banking network of over 400 community financial institutions across more than 40 states.“More than ever, community bankers will need to partner with each other as we contribute to the rebuilding of our country’s economy,” said Melville. “Jesse joins our team with a proven background in team building and relationship development. I look forward to working with Jesse and his team as they impact...

Continue reading

Genmab to Present at Morgan Stanley 18th Annual Global Healthcare Conference

Media ReleaseGenmab A/S (Nasdaq:GMAB) announced today that its CEO, Jan van de Winkel, Ph.D. and CFO Anthony Pagano, will participate in a virtual fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference at 11:45 AM EDT / 5:45 PM CEST on September 15, 2020.  A webcast of the event, which will include brief opening remarks followed by a question-and-answer session, will be available on Genmab’s website at https://ir.genmab.com/events-and-presentations#contentAbout GenmabGenmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company is the creator of the following approved antibodies: DARZALEX® (daratumumab, under agreement with Janssen Biotech, Inc.) for the treatment of certain...

Continue reading

Conduent Teams Up with Buoy Health and IBM Watson Health to Help its Clients Manage COVID-19 Related Workplace Challenges

FLORHAM PARK, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT), a business process services and solutions company, today announced a collaboration with Buoy Health and IBM Watson Health to integrate both companies’ cutting edge technologies and timely health care resources onto Conduent’s Life@Work platform.  Conduent clients can now use the HR platform to access Buoy’s full digital navigation product portfolio, which includes artificial intelligence (AI) driven tools that help people get the right care at the right time, and IBM Return-to-Workplace Advisor, a data and AI-driven application that can assist companies in managing a safe and effective return to the workplace.Conduent designed the Life@Work platform to offer clients and their employees easy access to the most comprehensive suite of digitally-enabled...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.